Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
teplizumab (MGA031)
print preview
bookmark
share with colleague
General Information
Company
MacroGenics Inc.
Description
Humanized mAb against CD3
Molecular Target
CD3
Mechanism of Action
Binds CD3
Latest Stage of Development
Phase III
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information